FCER1A
High affinity immunoglobulin epsilon receptor subunit alpha
Also known as: FCE1A, FcepsilonRIalpha, FCERA_HUMAN, FCERIA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P12319
- Gene
- FCER1A
- Ensembl
- ENSG00000179639
- Chromosome
- 1
- Canonical length
- 257 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins
OverviewNCBI Gene
The immunoglobulin epsilon receptor (IgE receptor) is the initiator of the allergic response. When two or more high-affinity IgE receptors are brought together by allergen-bound IgE molecules, mediators such as histamine that are responsible for allergy symptoms are released. This receptor is comprised of an alpha subunit, a beta subunit, and two gamma subunits. The protein encoded by this gene represents the alpha subunit. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
257 residues, UniProt reviewed canonical sequence.
>P12319|FCER1A
1 MAPAMESPTL LCVALLFFAP DGVLAVPQKP KVSLNPPWNR IFKGENVTLT CNGNNFFEVS
61 STKWFHNGSL SEETNSSLNI VNAKFEDSGE YKCQHQQVNE SEPVYLEVFS DWLLLQASAE
121 VVMEGQPLFL RCHGWRNWDV YKVIYYKDGE ALKYWYENHN ISITNATVED SGTYYCTGKV
181 WQLDYESEPL NITVIKAPRE KYWLQFFIPL LVVILFAVDT GLFISTQQQV TFLLKIKRTR
241 KGFRLLNPHP KPNPKNNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FCER1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- skin: 35 nTPM
- esophagus: 24 nTPM
- breast: 18 nTPM
- gallbladder: 16 nTPM
- lung: 15 nTPM
- bone marrow: 15 nTPM
Single-cell type
- cdc: 1,200 nCPM
- mast cells: 155 nCPM
- macrophages: 149 nCPM
- megakaryocyte progenitors: 115 nCPM
- megakaryocyte-erythroid progenitors: 98 nCPM
- pdcs: 96 nCPM
Immune cell
- basophil: 21,795 nTPM
- myeloid DC: 2,656 nTPM
- plasmacytoid DC: 365 nTPM
- total PBMC: 133 nTPM
- eosinophil: 37 nTPM
- neutrophil: 17 nTPM
Brain region
- pons: 0.8 nTPM
- hypothalamus: 0.7 nTPM
- choroid plexus: 0.5 nTPM
- medulla oblongata: 0.5 nTPM
- midbrain: 0.4 nTPM
- white matter: 0.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FCER1A.
Disease | AutoantibodyPubMed
Conditions in which antibodies against FCER1A are reported. Each links to that disease's full target list.
- Urticaria 26
Showing 1 of 2 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for FCER1A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
36 publications
- Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship.
1998 · J Clin Invest · RCR 5.9 · 203 citations - Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies.
2008 · J Invest Dermatol · RCR 3.3 · 112 citations - Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
2007 · J Allergy Clin Immunol · RCR 2.5 · 92 citations - Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria.
2006 · Ann Allergy Asthma Immunol · RCR 2.3 · 64 citations - Identification of the etiologies of chronic urticaria in children: a prospective study of 94 patients.
2010 · Pediatr Allergy Immunol · RCR 2.3 · 56 citations
Show 20 more of 36 total
- Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria.
2000 · J Allergy Clin Immunol · RCR 2.3 · 74 citations - Evidence of in vivo basophil activation in chronic idiopathic urticaria.
2006 · Clin Exp Allergy · RCR 2 · 77 citations - Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit.
2016 · J Allergy Clin Immunol · RCR 2 · 47 citations - Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria.
2000 · Allergy · RCR 2 · 56 citations - The anti-IgE/anti-FcepsilonRIalpha autoantibody network in allergic and autoimmune diseases.
1999 · Clin Exp Allergy · RCR 1.8 · 74 citations - Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients.
2020 · J Microbiol Immunol Infect · RCR 1.8 · 23 citations - Secretion of cytokines, histamine and leukotrienes in chronic urticaria.
2002 · Int Arch Allergy Immunol · RCR 1.8 · 61 citations - Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63.
2005 · J Allergy Clin Immunol · RCR 1.6 · 45 citations - Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria.
2010 · J Invest Dermatol · RCR 1.5 · 34 citations - Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria.
2004 · Br J Dermatol · RCR 1.5 · 47 citations - Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide.
2002 · Ann Allergy Asthma Immunol · RCR 1.4 · 39 citations - Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid.
1999 · Eur J Immunol · RCR 1.4 · 50 citations - Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria.
2020 · Asia Pac Allergy · RCR 1.1 · 15 citations - Correlation between T-cell and mast cell activity in patients with chronic urticaria.
2003 · Int Arch Allergy Immunol · RCR 1 · 39 citations - Molecular aspects of allergy.
2002 · Mol Aspects Med · RCR 1 · 44 citations - Natural anti-FcepsilonRIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria.
2004 · J Autoimmun · RCR 1 · 30 citations - The autoimmune nature of chronic urticaria.
2008 · Allergy Asthma Proc · RCR 1 · 24 citations - A rapid method of detecting autoantibody against FcεRIα for chronic spontaneous urticaria.
2014 · PLoS One · RCR 0.9 · 18 citations - Most chronic urticaria is food-dependent, and not idiopathic.
1998 · Exp Dermatol · RCR 0.9 · 20 citations - [Autoimmunity in chronic urticaria. A historical and current perspective].
2022 · Rev Alerg Mex · RCR 0.8 · 6 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.42
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- eosinophil degranulation
- immunoglobulin mediated immune response
- mast cell degranulation
- type 2 immune response
- type I hypersensitivity
Molecular functions
- IgE binding
- high-affinity IgE receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FCER1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FCER1A as an antibody target. Whether an autoantibody or antibody against FCER1A could matter depends on whether native FCER1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FCER1A is annotated at the cell surface, where native FCER1A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FCER1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...